Schulte P A
Division of Surveillance, Hazard Evaluations and Field Studies, National Institute for Occupational Safety and Health, Cincinnati, Ohio 45226-1998.
Environ Res. 1989 Apr;48(2):129-44. doi: 10.1016/s0013-9351(89)80029-5.
Biologic markers have been discussed extensively in the scientific literature in the past 5 years. That literature generally has focused on the promise and limitations of markers. Currently, a great amount of effort is under way in government, academia, and the private sector to move the field forward. This effort may be characterized by the inventory and review of potential markers and their use. The next requirement is to add a consideration of research and design strategies for the validation and use of biologic markers, especially as they pertain to the assessment of xenobiotic exposures and resultant health impairments. This paper delineates a conceptual framework for the validation and use of biologic markers. It expands on the concept of a continuum of events between ambient exposure to a xenobiotic substance and resultant clinical disease. Strategies for research and marker validation are presented. Biologic markers are considered useful in etiologic and mechanistic research, in secondary prevention of disease, in risk assessment, and in assessing the effectiveness of environmental controls.
在过去五年中,生物标志物在科学文献中得到了广泛讨论。该文献通常聚焦于标志物的前景与局限性。目前,政府、学术界和私营部门正在付出巨大努力以推动该领域向前发展。这种努力的特点可能是对潜在标志物及其用途进行清查和审查。接下来的要求是增加对生物标志物验证和使用的研究与设计策略的考量,尤其是当它们涉及到对外源化学物暴露及由此导致的健康损害的评估时。本文阐述了一个生物标志物验证和使用的概念框架。它扩展了从环境接触外源化学物质到由此导致临床疾病这一连续事件的概念。文中还介绍了研究和标志物验证的策略。生物标志物在病因学和机制研究、疾病二级预防、风险评估以及评估环境控制效果方面被认为是有用的。